Consistent with the above results, STOX1 expression in GBMs was consistently lower than that in astrocytomas, oligodendrogliomas (Grade II and III), and nontumor brain tissues (Figure 1d–f). The gene discussed is STOX1; the disease is astrocytoma (excluding glioblastoma).